BJ
ELDN icon

BlackRock Japan’s Eledon Pharmaceuticals ELDN Stock Holding History

BlackRock Japan’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11
Closed -$10K – 1344
2016
Q2 		$10K Hold
11
– – ﹤0.01% 1276
2016
Q1 		$10K Buy
11
+5
+83% +$4.91K ﹤0.01% 1287
2015
Q4 		$9K Buy
+6
New +$10.5K ﹤0.01% 1276

Other funds holding ELDN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Japan's ELDN Position: Q3 2016 in Review

BlackRock Japan sold out of Eledon Pharmaceuticals (ELDN) in Q3 2016, closing a stake of 11 shares — an estimated $10K sold.

BlackRock Japan first reported a position in ELDN in Q4 2015 and held it in 3 quarters. The position peaked at $10K in Q2 2016. 44 funds tracked by Wall St. Rank hold ELDN as of Q3 2016.

  • BlackRock Japan reported no remaining Eledon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 11 Eledon Pharmaceuticals shares in Q3 2016, an estimated $10K.
  • BlackRock Japan first reported a position in Eledon Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • BlackRock Japan's Eledon Pharmaceuticals position peaked at $10K in Q2 2016.
  • 44 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.